Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

Author: K-STOCK Editor

[Disclosure] SK hynix (000660 / SKHY) – Provisional Operating Results (Fair Disclosure) / 2024-01-25

[Disclosure] SK hynix (000660 / SKHY) – Provisional Operating Results (Fair Disclosure) / 2024-01-25

Disclosures
[Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2024-01-25

[Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2024-01-25

Disclosures
[Disclosure] Hyundai Motor (005380) – Provisional Consolidated Earnings Results / 2024-01-25

[Disclosure] Hyundai Motor (005380) – Provisional Consolidated Earnings Results / 2024-01-25

Disclosures
[Disclosure] Hyundai Motor (005380) – Change in Sales or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-25

[Disclosure] Hyundai Motor (005380) – Change in Sales or Profit/Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-25

Disclosures
[Disclosure] Hyundai Motor (005380) – Decision on Cash and In-Kind Dividend / 2024-01-25

[Disclosure] Hyundai Motor (005380) – Decision on Cash and In-Kind Dividend / 2024-01-25

Disclosures
[Disclosure] Hyundai Motor (005380) – Future Business and Management Plans / 2024-01-25

[Disclosure] Hyundai Motor (005380) – Future Business and Management Plans / 2024-01-25

Disclosures
[Disclosure] Hyundai Motor (005380) – Status of Compliance Program (CP) Operation / 2024-01-25

[Disclosure] Hyundai Motor (005380) – Status of Compliance Program (CP) Operation / 2024-01-25

Disclosures
[Disclosure] Samsung Biologics (207940) – Provisional Performance (Consolidated Financial Results) / 2024-01-24

[Disclosure] Samsung Biologics (207940) – Provisional Performance (Consolidated Financial Results) / 2024-01-24

Disclosures
[Disclosure] Samsung Biologics (207940) – Change in Profit and Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-24

[Disclosure] Samsung Biologics (207940) – Change in Profit and Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-24

Disclosures
[Disclosure] Samsung Biologics (207940) – Outlook on Business Performance (Consolidated Financial Results) / 2024-01-24

[Disclosure] Samsung Biologics (207940) – Outlook on Business Performance (Consolidated Financial Results) / 2024-01-24

Disclosures

Posts pagination

Previous 1 … 238 239 240 … 242 Next

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme